Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 11 December, 2025
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 532719 | NSE: BLKASHYAP

BL Kashyap & Sons Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: December 11, 2025, 3:53 pm

Market Cap 1,101 Cr.
Current Price 48.8
High / Low 84.7/42.7
Stock P/E
Book Value 23.3
Dividend Yield0.00 %
ROCE8.08 %
ROE2.00 %
Face Value 1.00
PEG Ratio0.00

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for BL Kashyap & Sons Ltd

Competitors of BL Kashyap & Sons Ltd

Stock Name Market Cap Current Price High / Low Stock P/E Book Value Dividend Yield ROCE ROE Face Value
Modern Engineering and Projects Ltd 50.3 Cr. 32.6 49.9/22.54.79 39.40.00 %20.5 %25.9 % 10.0
Modis Navnirman Ltd 659 Cr. 336 409/22080.3 46.50.00 %12.9 %9.88 % 10.0
Modulex Construction Technologies Ltd 141 Cr. 20.4 35.7/18.0 44.70.00 %2.51 %1.54 % 10.0
MPDL Ltd 31.5 Cr. 42.6 92.7/38.0 1270.00 %2.87 %4.16 % 10.0
IITL Projects Ltd 32.4 Cr. 65.0 77.9/47.1 2.120.00 %16.6 %% 10.0
Industry Average17,017.57 Cr246.3778.35138.420.16%16.68%21.32%21.41

All Competitor Stocks of BL Kashyap & Sons Ltd

Quarterly Result

MetricJun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
Sales 289293253276253327324341350267242294336
Expenses 257272231253228298300308319247236287310
Operating Profit 322122232529243332206726
OPM % 11%7%9%8%10%9%7%10%9%8%3%2%8%
Other Income 059-3031189129153
Interest 13131213111112151114101211
Depreciation 3322233333333
Profit before tax 171116-231417102227152715
Tax % 30%45%-129%41%28%29%31%-6%24%38%41%149%26%
Net Profit 12637-3210127242091-311
EPS in Rs 0.520.251.62-1.420.440.530.311.050.900.420.05-0.140.48

Last Updated: August 19, 2025, 10:50 pm

Below is a detailed analysis of the quarterly data for BL Kashyap & Sons Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

  • For Sales, as of Jun 2025, the value is 336.00 Cr.. The value appears strong and on an upward trend. It has increased from 294.00 Cr. (Mar 2025) to 336.00 Cr., marking an increase of 42.00 Cr..
  • For Expenses, as of Jun 2025, the value is 310.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 287.00 Cr. (Mar 2025) to 310.00 Cr., marking an increase of 23.00 Cr..
  • For Operating Profit, as of Jun 2025, the value is 26.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Mar 2025) to 26.00 Cr., marking an increase of 19.00 Cr..
  • For OPM %, as of Jun 2025, the value is 8.00%. The value appears strong and on an upward trend. It has increased from 2.00% (Mar 2025) to 8.00%, marking an increase of 6.00%.
  • For Other Income, as of Jun 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15.00 Cr. (Mar 2025) to 3.00 Cr., marking a decrease of 12.00 Cr..
  • For Interest, as of Jun 2025, the value is 11.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 12.00 Cr. (Mar 2025) to 11.00 Cr., marking a decrease of 1.00 Cr..
  • For Depreciation, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
  • For Profit before tax, as of Jun 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Mar 2025) to 15.00 Cr., marking an increase of 8.00 Cr..
  • For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 149.00% (Mar 2025) to 26.00%, marking a decrease of 123.00%.
  • For Net Profit, as of Jun 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from -3.00 Cr. (Mar 2025) to 11.00 Cr., marking an increase of 14.00 Cr..
  • For EPS in Rs, as of Jun 2025, the value is 0.48. The value appears strong and on an upward trend. It has increased from -0.14 (Mar 2025) to 0.48, marking an increase of 0.62.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 3:50 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 1,3498348609241,0127698207621,1581,1101,2451,1541,140
Expenses 1,2968167928349277137996991,0671,0121,1341,0881,080
Operating Profit 531968898557216390981106560
OPM % 4%2%8%10%8%7%3%8%8%9%9%6%5%
Other Income -6531230315-22741-16124538
Interest 97818283775969595551494747
Depreciation 23472113121212111010101213
Profit before tax -132-78-12-627-10-82-16621635038
Tax % -36%-26%-48%-181%23%-34%-23%8,490%33%-7%17%45%
Net Profit -85-58-6521-6-63-584422532718
EPS in Rs -4.14-2.82-0.290.240.98-0.28-2.79-2.591.950.982.331.220.81
Dividend Payout % 0%0%0%0%0%0%0%0%0%0%0%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)31.76%89.66%183.33%320.00%-128.57%-950.00%7.94%175.86%-50.00%140.91%-49.06%
Change in YoY Net Profit Growth (%)0.00%57.89%93.68%136.67%-448.57%-821.43%957.94%167.93%-225.86%190.91%-189.97%

BL Kashyap & Sons Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:3%
5 Years:7%
3 Years:0%
TTM:-15%
Compounded Profit Growth
10 Years:9%
5 Years:22%
3 Years:-2%
TTM:-72%
Stock Price CAGR
10 Years:21%
5 Years:55%
3 Years:39%
1 Year:-35%
Return on Equity
10 Years:3%
5 Years:6%
3 Years:8%
Last Year:3%

Last Updated: September 5, 2025, 2:31 pm

Balance Sheet

Last Updated: December 10, 2025, 3:54 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 21212121222323232323232323
Reserves 444384379414476493436357400422474501503
Borrowings 682762797745605552520519380320310316309
Other Liabilities 695596637595645756839622629531606676774
Total Liabilities 1,8411,7621,8331,7741,7481,8241,8181,5201,4321,2951,4121,5161,608
Fixed Assets 1409099431414412311236230133154192220
CWIP 11713013995979495-0-0-0200
Investments 2992993011111000000
Other Assets 1,2851,2441,2941,2471,2361,3161,4121,2841,2021,1621,2561,3231,388
Total Assets 1,8411,7621,8331,7741,7481,8241,8181,5201,4321,2951,4121,5161,608

Below is a detailed analysis of the balance sheet data for BL Kashyap & Sons Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2025, the value is 23.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 23.00 Cr..
  • For Reserves, as of Sep 2025, the value is 503.00 Cr.. The value appears strong and on an upward trend. It has increased from 501.00 Cr. (Mar 2025) to 503.00 Cr., marking an increase of 2.00 Cr..
  • For Borrowings, as of Sep 2025, the value is 309.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 316.00 Cr. (Mar 2025) to 309.00 Cr., marking a decrease of 7.00 Cr..
  • For Other Liabilities, as of Sep 2025, the value is 774.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 676.00 Cr. (Mar 2025) to 774.00 Cr., marking an increase of 98.00 Cr..
  • For Total Liabilities, as of Sep 2025, the value is 1,608.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,516.00 Cr. (Mar 2025) to 1,608.00 Cr., marking an increase of 92.00 Cr..
  • For Fixed Assets, as of Sep 2025, the value is 220.00 Cr.. The value appears strong and on an upward trend. It has increased from 192.00 Cr. (Mar 2025) to 220.00 Cr., marking an increase of 28.00 Cr..
  • For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
  • For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
  • For Other Assets, as of Sep 2025, the value is 1,388.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,323.00 Cr. (Mar 2025) to 1,388.00 Cr., marking an increase of 65.00 Cr..
  • For Total Assets, as of Sep 2025, the value is 1,608.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,516.00 Cr. (Mar 2025) to 1,608.00 Cr., marking an increase of 92.00 Cr..

Notably, the Reserves (503.00 Cr.) exceed the Borrowings (309.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow - No data available for this post.

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-629.00-743.00-729.00-656.00-520.00-495.00-499.00-456.00-290.00-222.00-200.00-251.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days107169187156127176171210110138111138
Inventory Days259414384333261372347201240105130
Days Payable150188163118152170179116140136154
Cash Conversion Cycle21539640737123637833921019523880113
Working Capital Days37739413-19-7418441646894
ROCE %4%0%6%7%9%5%2%8%10%14%14%8%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Promoters61.56%61.58%61.61%61.65%61.65%61.65%61.65%61.65%61.65%61.67%61.69%61.70%
FIIs0.54%0.22%0.43%0.35%0.30%0.89%1.65%1.87%0.59%0.72%0.40%0.34%
DIIs0.00%0.09%0.00%0.00%0.00%0.02%0.00%0.00%0.35%0.92%0.88%0.59%
Public37.91%38.12%37.96%38.00%38.04%37.44%36.70%36.48%37.40%36.68%37.03%37.37%
No. of Shareholders25,32524,60225,09926,22530,43038,58139,13345,12245,65144,71244,23144,066

Shareholding Pattern Chart

No. of Shareholders

BL Kashyap & Sons Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.001.001.001.001.00
Basic EPS (Rs.) 1.222.330.981.95-2.59
Diluted EPS (Rs.) 1.222.330.981.95-2.59
Cash EPS (Rs.) 1.772.791.412.41-2.10
Book Value[Excl.RevalReserv]/Share (Rs.) 23.2322.0219.7318.7616.82
Book Value[Incl.RevalReserv]/Share (Rs.) 23.2322.0219.7318.7616.82
Revenue From Operations / Share (Rs.) 51.1755.2049.2451.3433.81
PBDIT / Share (Rs.) 4.065.435.224.103.90
PBIT / Share (Rs.) 3.514.974.793.643.41
PBT / Share (Rs.) 2.232.810.912.92-0.03
Net Profit / Share (Rs.) 1.222.330.981.95-2.59
NP After MI And SOA / Share (Rs.) 1.222.330.981.95-2.59
PBDIT Margin (%) 7.929.8410.607.9911.54
PBIT Margin (%) 6.859.009.727.0910.09
PBT Margin (%) 4.355.081.855.69-0.08
Net Profit Margin (%) 2.384.221.993.79-7.66
NP After MI And SOA Margin (%) 2.384.221.993.79-7.66
Return on Networth / Equity (%) 5.2410.584.9710.39-15.40
Return on Capital Employeed (%) 11.6017.1618.3312.3910.79
Return On Assets (%) 1.813.721.703.06-3.84
Long Term Debt / Equity (X) 0.070.060.080.150.29
Total Debt / Equity (X) 0.600.620.710.861.11
Asset Turnover Ratio (%) 0.780.910.810.760.44
Current Ratio (X) 1.401.371.361.211.27
Quick Ratio (X) 1.170.710.870.770.82
Inventory Turnover Ratio (X) 1.591.571.551.841.14
Interest Coverage Ratio (X) 1.932.512.291.691.48
Interest Coverage Ratio (Post Tax) (X) 1.192.082.131.100.32
Enterprise Value (Cr.) 1439.171822.80959.52931.69821.69
EV / Net Operating Revenue (X) 1.251.460.860.801.08
EV / EBITDA (X) 15.7314.888.1510.079.34
MarketCap / Net Operating Revenue (X) 1.001.240.630.510.55
Price / BV (X) 2.213.121.571.411.12
Price / Net Operating Revenue (X) 1.001.240.630.510.55
EarningsYield 0.020.030.030.07-0.13

After reviewing the key financial ratios for BL Kashyap & Sons Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
  • For Basic EPS (Rs.), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 5. It has decreased from 2.33 (Mar 24) to 1.22, marking a decrease of 1.11.
  • For Diluted EPS (Rs.), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 5. It has decreased from 2.33 (Mar 24) to 1.22, marking a decrease of 1.11.
  • For Cash EPS (Rs.), as of Mar 25, the value is 1.77. This value is below the healthy minimum of 3. It has decreased from 2.79 (Mar 24) to 1.77, marking a decrease of 1.02.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 23.23. It has increased from 22.02 (Mar 24) to 23.23, marking an increase of 1.21.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 23.23. It has increased from 22.02 (Mar 24) to 23.23, marking an increase of 1.21.
  • For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 51.17. It has decreased from 55.20 (Mar 24) to 51.17, marking a decrease of 4.03.
  • For PBDIT / Share (Rs.), as of Mar 25, the value is 4.06. This value is within the healthy range. It has decreased from 5.43 (Mar 24) to 4.06, marking a decrease of 1.37.
  • For PBIT / Share (Rs.), as of Mar 25, the value is 3.51. This value is within the healthy range. It has decreased from 4.97 (Mar 24) to 3.51, marking a decrease of 1.46.
  • For PBT / Share (Rs.), as of Mar 25, the value is 2.23. This value is within the healthy range. It has decreased from 2.81 (Mar 24) to 2.23, marking a decrease of 0.58.
  • For Net Profit / Share (Rs.), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 2. It has decreased from 2.33 (Mar 24) to 1.22, marking a decrease of 1.11.
  • For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 2. It has decreased from 2.33 (Mar 24) to 1.22, marking a decrease of 1.11.
  • For PBDIT Margin (%), as of Mar 25, the value is 7.92. This value is below the healthy minimum of 10. It has decreased from 9.84 (Mar 24) to 7.92, marking a decrease of 1.92.
  • For PBIT Margin (%), as of Mar 25, the value is 6.85. This value is below the healthy minimum of 10. It has decreased from 9.00 (Mar 24) to 6.85, marking a decrease of 2.15.
  • For PBT Margin (%), as of Mar 25, the value is 4.35. This value is below the healthy minimum of 10. It has decreased from 5.08 (Mar 24) to 4.35, marking a decrease of 0.73.
  • For Net Profit Margin (%), as of Mar 25, the value is 2.38. This value is below the healthy minimum of 5. It has decreased from 4.22 (Mar 24) to 2.38, marking a decrease of 1.84.
  • For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.38. This value is below the healthy minimum of 8. It has decreased from 4.22 (Mar 24) to 2.38, marking a decrease of 1.84.
  • For Return on Networth / Equity (%), as of Mar 25, the value is 5.24. This value is below the healthy minimum of 15. It has decreased from 10.58 (Mar 24) to 5.24, marking a decrease of 5.34.
  • For Return on Capital Employeed (%), as of Mar 25, the value is 11.60. This value is within the healthy range. It has decreased from 17.16 (Mar 24) to 11.60, marking a decrease of 5.56.
  • For Return On Assets (%), as of Mar 25, the value is 1.81. This value is below the healthy minimum of 5. It has decreased from 3.72 (Mar 24) to 1.81, marking a decrease of 1.91.
  • For Long Term Debt / Equity (X), as of Mar 25, the value is 0.07. This value is below the healthy minimum of 0.2. It has increased from 0.06 (Mar 24) to 0.07, marking an increase of 0.01.
  • For Total Debt / Equity (X), as of Mar 25, the value is 0.60. This value is within the healthy range. It has decreased from 0.62 (Mar 24) to 0.60, marking a decrease of 0.02.
  • For Asset Turnover Ratio (%), as of Mar 25, the value is 0.78. It has decreased from 0.91 (Mar 24) to 0.78, marking a decrease of 0.13.
  • For Current Ratio (X), as of Mar 25, the value is 1.40. This value is below the healthy minimum of 1.5. It has increased from 1.37 (Mar 24) to 1.40, marking an increase of 0.03.
  • For Quick Ratio (X), as of Mar 25, the value is 1.17. This value is within the healthy range. It has increased from 0.71 (Mar 24) to 1.17, marking an increase of 0.46.
  • For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.59. This value is below the healthy minimum of 4. It has increased from 1.57 (Mar 24) to 1.59, marking an increase of 0.02.
  • For Interest Coverage Ratio (X), as of Mar 25, the value is 1.93. This value is below the healthy minimum of 3. It has decreased from 2.51 (Mar 24) to 1.93, marking a decrease of 0.58.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.19. This value is below the healthy minimum of 3. It has decreased from 2.08 (Mar 24) to 1.19, marking a decrease of 0.89.
  • For Enterprise Value (Cr.), as of Mar 25, the value is 1,439.17. It has decreased from 1,822.80 (Mar 24) to 1,439.17, marking a decrease of 383.63.
  • For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.25. This value is within the healthy range. It has decreased from 1.46 (Mar 24) to 1.25, marking a decrease of 0.21.
  • For EV / EBITDA (X), as of Mar 25, the value is 15.73. This value exceeds the healthy maximum of 15. It has increased from 14.88 (Mar 24) to 15.73, marking an increase of 0.85.
  • For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.00. This value is within the healthy range. It has decreased from 1.24 (Mar 24) to 1.00, marking a decrease of 0.24.
  • For Price / BV (X), as of Mar 25, the value is 2.21. This value is within the healthy range. It has decreased from 3.12 (Mar 24) to 2.21, marking a decrease of 0.91.
  • For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.00. This value is within the healthy range. It has decreased from 1.24 (Mar 24) to 1.00, marking a decrease of 0.24.
  • For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.02, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of BL Kashyap & Sons Ltd as of December 11, 2025 is: 5.70

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of December 11, 2025, BL Kashyap & Sons Ltd is Overvalued by 88.32% compared to the current share price 48.80

Default values used*: Default value of 15 for Stock P/E is used

Intrinsic Value of BL Kashyap & Sons Ltd as of December 11, 2025 is: 4.78

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of December 11, 2025, BL Kashyap & Sons Ltd is Overvalued by 90.20% compared to the current share price 48.80

Default values used*: Default value of 15 for Stock P/E is used

Last 5 Year EPS CAGR: -16.11%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
    1. The stock has a low average ROCE of 7.25%, which may not be favorable.
    2. The stock has a high average Working Capital Days of 48.58, which may not be favorable.
    3. The stock has a high average Cash Conversion Cycle of 264.83, which may not be favorable.
    4. The company has higher borrowings (524.38) compared to reserves (437.15), which may suggest financial risk.
    5. The company has not shown consistent growth in sales (382.77) and profit (-4.31).

    Stock Analysis

    • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in BL Kashyap & Sons Ltd:
      1. Net Profit Margin: 2.38%
        • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
      2. ROCE: 11.6% (Industry Average ROCE: 16.68%)
        • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
      3. ROE%: 5.24% (Industry Average ROE: 21.32%)
        • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
      4. Interest Coverage Ratio (Post Tax): 1.19
        • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
      5. Quick Ratio: 1.17
        • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
      6. Stock P/E: 0 (Industry average Stock P/E: 78.35)
        • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
      7. Total Debt / Equity: 0.6
        • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
      The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
      Stock Rating:

    About the Company - Qualitative Analysis

    B L Kashyap & Sons Ltd. is a Public Limited Listed company incorporated on 08/05/1989 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L74899DL1989PLC036148 and registration number is 036148. Currently Company is involved in the business activities of Construction of buildings. Company's Total Operating Revenue is Rs. 1142.30 Cr. and Equity Capital is Rs. 22.54 Cr. for the Year ended 31/03/2025.
    INDUSTRYADDRESSCONTACT
    Construction, Contracting & Engineering409, 4th Floor, New Delhi Delhi 110025info@blkashyap.com
    http://www.blkashyap.com
    Management
    NamePosition Held
    Mr. Vinod KashyapChairman
    Mr. Vineet KashyapManaging Director
    Mr. Vikram KashyapJoint Managing Director
    Mr. Vivek TalwarIndependent Director
    Mr. Settihalli BasavarajIndependent Director
    Mrs. Neelam Naresh KothariIndependent Director
    Mr. Gopinath AmbadithodyIndependent Director
    Mr. Vishal Sharat OhriNominee Director

    FAQ

    What is the intrinsic value of BL Kashyap & Sons Ltd?

    BL Kashyap & Sons Ltd's intrinsic value (as of 11 December 2025) is 5.70 which is 88.32% lower the current market price of 48.80, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 1,101 Cr. market cap, FY2025-2026 high/low of 84.7/42.7, reserves of ₹503 Cr, and liabilities of 1,608 Cr.

    What is the Market Cap of BL Kashyap & Sons Ltd?

    The Market Cap of BL Kashyap & Sons Ltd is 1,101 Cr..

    What is the current Stock Price of BL Kashyap & Sons Ltd as on 11 December 2025?

    The current stock price of BL Kashyap & Sons Ltd as on 11 December 2025 is 48.8.

    What is the High / Low of BL Kashyap & Sons Ltd stocks in FY 2025-2026?

    In FY 2025-2026, the High / Low of BL Kashyap & Sons Ltd stocks is 84.7/42.7.

    What is the Stock P/E of BL Kashyap & Sons Ltd?

    The Stock P/E of BL Kashyap & Sons Ltd is .

    What is the Book Value of BL Kashyap & Sons Ltd?

    The Book Value of BL Kashyap & Sons Ltd is 23.3.

    What is the Dividend Yield of BL Kashyap & Sons Ltd?

    The Dividend Yield of BL Kashyap & Sons Ltd is 0.00 %.

    What is the ROCE of BL Kashyap & Sons Ltd?

    The ROCE of BL Kashyap & Sons Ltd is 8.08 %.

    What is the ROE of BL Kashyap & Sons Ltd?

    The ROE of BL Kashyap & Sons Ltd is 2.00 %.

    What is the Face Value of BL Kashyap & Sons Ltd?

    The Face Value of BL Kashyap & Sons Ltd is 1.00.

    Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in BL Kashyap & Sons Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE